Clinical Trial Update: A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED) [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating MK0557 in obese subjects. The study, sponsored by Merck Sharp & Dohme LLC, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• MK0557

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 2 | Status: COMPLETED